Position DescriptionThe Department of Radiology in the School of Medicine at theUniversity of Washington in Seattle is seeking applications for onefull-time faculty position at the level of Assistant Professor,Associate Professor, or Full Professor without tenure, commensuratewith experience, to join faculty members in the CardiothoracicImaging section with an anticipated start date of September 1,2021. School of Medicine faculty members have an annualservice period of 12 months (July 1-June 30).The section seeks an individual who will engage in scholarlywork, teaching, and clinical service in a mixture of pulmonary andcardiac imaging. The successful candidate will work withcardiovascular MRI and CT, chest CT and chest radiographs.The Cardiothoracic Imaging section currently has six facultymembers with a range of expertise in pulmonary and cardiac imagingand provides pulmonary, vascular, cardiac CT and MR diagnosticinterpretations. The section maintains close relationshipswith internal medicine, pulmonology, oncology, bone marrowtransplantation, cardiology, and cardiac and thoracic surgeryservices at all hospital sites; the University of WashingtonMedical Center Montlake and Northwest campuses, Harborview MedicalCenter, and Seattle Cancer Care Alliance. CardiothoracicImaging has an active fellowship program and faculty areresponsible for the instruction of cardiothoracic imaging fellows,in addition to medical students and diagnostic radiologyresidents.The University of Washington (UW) is a leading referral centerfor interstitial lung diseases, lung transplantation, thoracicsurgery, thoracic oncology, structural and congenital heartdisease, interventional cardiology and hematology. Cardiothoracic Imaging conducts conferences for inpatient internalmedicine services, pulmonary medicine, interventional cardiology,oncology, and the Fred Hutchinson Cancer Research Institute, apremier transplantation center.UW is listed as one of the nation’s top public educational andresearch institutions, and the School of Medicine has been rankedsecond in the world, among the top two recipients of federalresearch grants. Our hospitals consistently rank among thevery best. The Department of Radiology is internationallyrecognized as dynamic, progressive, and high impact, consummatewith UW Medicine’s ranking as one of the nation’s leadinghealthcare delivery enterprises. All UW faculty engage inteaching, research, and service.Seattle is a cosmopolitan city that ranks among the top urbanareas for quality of life. It is a hub for aerospace,technology, and maritime industries, and is a headquartered by someof the world’s largest companies. Seattle is alsofamily-friendly with nationally ranked schools. The proximityof water, forests, and mountains attract nature lovers and outdoorenthusiasts. Our faculty enjoy outstanding benefits, strongsupport for professional growth, and an environment noted fordiversity, community involvement, intellectual excitement, andartistic pursuits. QualificationsCandidates should meet the following requirements:D., or foreign equivalent, in medicine and eligibility for fullmedical licensure in Washington StateBe board certified or board eligible in diagnosticradiologyCompletion of an ACGME-accredited residency in diagnosticradiology and have completed a fellowship training incardiothoracic imagingDemonstrated record of scientific presentations orpublicationsIn order to be eligible for University sponsorship for an H-1Bvisa, graduates of foreign (non-U.S.) medical schools must showsuccessful completion of all three steps of the U.S. MedicalLicensing Exam (USMLE), or equivalent as determined by theSecretary of Health and Human Services. InstructionsPlease upload the following required forms as part of theapplication process: Updated CV and a Letter of Interest orCover Letter. In your cover letter, please includeinformation about your experiences with and/or commitments todiversity, equity, and inclusion. Apply online throughInterfolio here: https://apply.interfolio.com/85069Address inquiries to:Karen Ordovas, M.D., MASProfessor, Department of RadiologyUniversity of Washington1959 NE Pacific StreetSeattle, WA 98195Email: [email protected] Equal Employment Opportunity StatementUniversity of Washington is an affirmative action and equalopportunity employer. All qualified applicants will receiveconsideration for employment without regard to race, color, creed,religion, national origin, sex, sexual orientation, marital status,pregnancy, genetic information, gender identity or expression, age,disability, or protected veteran status.Commitment to DiversityThe University of Washington is committed to buildingdiversity among its faculty, librarian, staff, and studentcommunities, and articulates that commitment in the UW DiversityBlueprint (http://www.washington.edu/diversity/diversity-blueprint/).Additionally, the University’s Faculty Code recognizes facultyefforts in research, teaching and/or service that address diversityand equal opportunity as important contributions to a facultymember’s academic profile and responsibilities(https://www.washington.edu/admin/rules/policies/FCG/FCCH24.html#2432).
The French industrial gas giant this morning reported group revenue of €5.4bn for the first quarter, up 0.6% on a comparable basis which Air Liquide attributed to a strong business model.Gas & Services posted robust growth of 1.1%. Engineering & Construction (-44%) has been impacted by the Covid-19 pandemic, which notably led to the closure of the Chinese engineering and fabrication centre and the postponement by a few months of several projects.Global Markets & Technologies maintained excellent momentum and enjoyed dynamic growth of 13.6%.As the positive currency impact of 0.8% did not offset the major negative energy impact of -2.5% and the significant scope impact of -0.2%, group revenue as published was down -1.3%.Commenting on the Q1 results, Benoît Potier, Chairman and CEO of Air Liquide, said, “The resilience of sales reflects the solid business model of the group, characterised by the diversity of its markets and its geographies, as well as by the significant proportion of long-term contracts in its business portfolio.”“Gas & Services and Global Markets & Technologies progressed, while Engineering & Construction sales fell sharply, mainly reflecting the postponement of construction projects for third party clients to a later date.”RegionsGas & Services revenue in the Americas stood at €2.1bn and was up 1.3%, driven notably by Healthcare (+10%) and Large Industries (+2.7%), in particular hydrogen sales and cogeneration.Despite the public health crisis which impacted the region as of the end of March, Electronics sales were up 0.6% and Industrial Merchant sales were stable at -0.2%, with price impacts that remained high.Revenue in Europe totalled €1.8bn over the quarter, up 2.7%. Large Industries sales were down slightly by 0.6%.Industrial Merchant, which was down 2.7%, was the most affected by the public health crisis that hit the region in mid-March.Healthcare, which represented 39% of Gas & Services sales in Europe, has been playing a major role in the fight against Covid-19. Revenue for this business line increased by 10.8%, driven by strong sales of medical gases in March as well as medical hydroalcoholic gel produced by its subsidiary Schülke in Germany.Revenue in Asia Pacific reached €1.1bn, down 0.9%. Air Liquide said this region suffered the greatest impact of the Covid-19 pandemic during Q1, in particular in China where sales were down 2.5%.Large Industries (-2.1%) benefited from the resilience of its business model, whereas Industrial Merchant (-5.3%) was hit the hardest.Electronics momentum remained strong (+4.9%), with several unit start-ups and ramp-ups and despite an unfavourable comparison effect compared with high Equipment & Installation sales in 2019.Revenue in Middle East and Africa stood at €139m, a decrease of -5.8%, particularly marked by a customer maintenance turnaround at a large hydrogen production unit in Saudi Arabia.To a lesser extent, Air Liquide said Industrial Merchant also slowed due to lockdown measures taken in Persian Gulf countries and in South Africa, even though sales remained stable overall in Africa and strong in Egypt and India.The Healthcare activity continued to grow markedly, in particular in Saudi Arabia.“In Gas & Services, which accounts for 96% of group sales, growth was particularly strong in Healthcare (+10%) and Electronics,” Potier said.“From a geographic perspective, Europe and the Americas continued to post sales growth, while the Asia-Pacific region was more penalised by the public health situation, particularly in China.”Covid-19Healthcare, which has played a major role in the fight against Covid-19, posted the strongest growth for Air Liquide in the first quarter, up 9.9%.Due to the spread of Covid-19 and based on information available at the end of the first quarter, Air Liquide said around 25% of start-ups initially scheduled for 2020 are very likely to be delayed by two to six months.As a result, the additional contribution to sales expected for 2020 should range between €150m and €180m, an amount which is lower than the €230m contribution initially forecast.At the end of the first quarter, Air Liquide said activity is recovering in China whereas Europe, Americas and Africa & Middle East are going through the critical phase of the public health crisis, for which the impact is expected to peak in the second quarter.“In the context of a global health emergency, the group is mobilised. It is taking an active part in the international support effort, whether this entails supplying healthcare facilities with medical oxygen or ventilators, having committed to producing 10,000 ventilators in 50 days in France,” Potier said.“In addition, a stepped-up cost containment program has been initiated to surpass the annual target of €400m of efficiencies. In the first quarter of 2020, €91m of efficiencies were generated.”“The cash flow is high, at more than 22% of sales. The group has also strengthened its position in terms of liquidities with a €1bn bond issue in March that was widely oversubscribed.”FutureIn the second quarter, Air Liquide said demand for air gases in Large Industries should weaken in the Steel sector, and to a lesser extent, in the Chemicals sector.Industrial Merchant should be the most impacted, in particular cylinder gas volumes, whereas Electronics should keep a steady pace.Air Liquide’s Healthcare teams will remain highly mobilised, notably to ensure supply of medical gases, ventilators, and hydroalcoholic gel to hospitals and patients.Once the containment period is over, a progressive recovery is expected, particularly driven by consumption markets, Electronics and Healthcare.“In terms of the health and economic environment, the most widely held hypothesis today is that the second quarter will be highly impacted by the crisis, followed by gradual relaxation of lockdown measures between the end of the second quarter and the beginning of the third quarter, depending on the continent,” Potier said.“Assuming this hypothesis, and given the company’s solid business model and the additional measures rolled out in 2020, Air Liquide is nonetheless confident in its ability to further increase its operating margin and to deliver net profit close to the 2019 level, at constant exchange rates.”
OWINGS MILLS, Md. — It’s appearing extremely likely that the Ravens will take the field against the Cleveland Browns in Week 17 without either of their starting offensive tackles as Eugene Monroe was designated as doubtful to play.Monroe hasn’t practiced all week after suffering an ankle injury in the fourth quarter of the Week 16 loss to Houston. He has been wearing a protective boot on his foot this week, and there hadn’t been much optimism that he’d improve enough to play against Cleveland.Rookie James Hurst would start at left tackle in place of Monroe after the undrafted free agent started four games at left tackle earlier this season after Monroe underwent arthroscopic knee surgery. Pro Bowl right guard Marshal Yanda would then slide to right tackle with rookie John Urschel assuming Yanda’s normal position.Defensive end Chris Canty (ankle/thigh) and linebacker Terrell Suggs (back/thigh) are both listed as questionable for Sunday’s game after missing practice all week, but both veterans are still considered likely to play in Week 17.Rookie running back Fitz Toussaint was also listed as questionable after being added to Friday’s injury report as a limited participant with a rib injury.Meanwhile, Browns head coach Mike Pettine confirmed that rookie quarterback Connor Shaw will start against the Ravens. Veteran Brian Hoyer (right shoulder) is doubtful to play and rookie Johnny Manziel was placed on injured reserve earlier this week.Cornerback Joe Haden (shoulder) was designated as questionable for Sunday’s game.Another piece of injury-related news announced Friday wasn’t a good sign for the Ravens’ postseason hopes as the Kansas City Chiefs announced quarterback Alex Smith has a lacerated spleen and won’t play against San Diego on Sunday. Backup Chase Daniel will make his second NFL start in Smith’s place.Of course, Baltimore needs a win over the Browns as well as the Chargers to lose to the Chiefs in order to make the playoffs as the final AFC wild card.“I mean, we’ve still got a job to do,” said linebacker Daryl Smith when asked about the Chiefs-Chargers game. “That’s [beating] the Cleveland Browns Sunday. Regardless of what happens, we’ve got to do our job and try to win this game.”The referee for Sunday’s game between Baltimore and Cleveland will be Gene Steratore.According to Weather.com, the forecast for Sunday’s game in Baltimore calls for temperatures in the low 50s with a 40 percent chance of rain.Below is Friday’s final injury report:BALTIMOREDOUBTFUL: T Eugene Monroe (ankle)QUESTIONABLE: DE Chris Canty (ankle/thigh), LB Terrell Suggs (back/thigh), RB Fitzgerald Touissant (ribs)CLEVELANDOUT: DL Ahtyba Rubin (ankle), C Ryan Seymour (hamstring)DOUBTFUL: QB Brian Hoyer (right shoulder/bicep)QUESTIONABLE: TE Gary Barnidge (rib), DL Desmond Bryant (thumb), CB Joe Haden (shoulder), WR Andrew Hawkins (thumb), LB Jabaal Sheard (foot), TE Ryan Taylor (elbow) , CB K’Waun Williams (hamstring)PROBABLE: WR Marlon Moore (knee)